Products

Somite is leveraging data and AI to introduce novel cell replacement therapies.

Interaction Voicemail Player is a standalone desktop application designed to streamline voicemail management across various email platforms, including Microsoft Outlook, Gmail, IBM Notes, and Novell GroupWise. It delivers voicemail messages as .wav file attachments, allowing users to access and manage their voicemails directly from their email clients or through the Customer Interaction Center client interface. Key Features and Functionality: - Unified Interface: Provides a consistent user ex

Added Matter is an AI-powered platform designed to revolutionize the patent process by automating key tasks such as drafting patent specifications, reviewing citations, and generating arguments for both patent prosecution and invalidity exercises. By leveraging generative AI, it enables patent professionals to significantly enhance productivity and efficiency. Key Features and Functionality: - Patent Drafting: Automatically generates comprehensive patent specifications in minutes using input c

Made Live is an AI-driven, end-to-end self-publishing platform tailored for authors of illustrated books, including children's picture books, comics, and graphic novels. It offers a comprehensive suite of tools that guide users through every stage of the publishing process—from initial planning and writing to storyboarding, illustrating, and final publishing. By integrating intuitive design features with expert guidance, Made Live empowers authors to bring their visual stories to life efficientl

Algen Biotechnologies is a pioneering therapeutics company that integrates advanced CRISPR gene-modulation with artificial intelligence to revolutionize drug discovery. Originating from Nobel Laureate Jennifer Doudna's lab at UC Berkeley, Algen focuses on developing innovative medicines targeting diseases with significant unmet needs, such as cancer and chronic inflammatory conditions. By reverse-engineering disease trajectories, Algen aims to identify and modulate disease-driving RNA pathways,

RealtyBundles provides a novel business model for real estate agencies and attractive investment opportunities for investors.

Weave Bio is an AI-native platform transforming regulatory workflows and accelerating how novel therapies reach patients faster.

GEn1E is a clinical-stage multi-target AI platform. They develop novel, next-gen, immunomodulators for rare & inflammatory diseases.

Aitia is a pioneering biotechnology company specializing in the application of causal artificial intelligence (AI) and Digital Twins technology to revolutionize drug discovery and development. By integrating vast multi-omic patient datasets with advanced computational models, Aitia constructs Gemini Digital Twins—virtual representations of human disease biology. These models enable researchers to uncover hidden disease mechanisms, identify novel therapeutic targets, and simulate drug responses,

BenevolentAI is a leading clinical-stage company that integrates artificial intelligence (AI) with scientific expertise to revolutionize drug discovery and development. By leveraging its proprietary Benevolent Platform™, the company uncovers novel biological insights, predicts new drug targets, and develops first-in-class or best-in-class therapeutics for complex diseases. This innovative approach aims to enhance the efficiency and success rates of bringing new medicines to patients. Key Featur

Signet Therapeutics is a clinical-stage biotechnology company pioneering the development of first-in-class targeted cancer therapies by integrating organoid disease models with artificial intelligence (AI). Their innovative approach accelerates drug discovery and enhances the precision of treatments, particularly for cancers that are unresponsive to conventional therapies. Key Features and Functionality: - Organoid Disease Models: Utilizes three-dimensional organoid models derived from patient

Nexco Analytics is a Swiss-based company specializing in artificial intelligence (AI), bioinformatics, and data analysis services tailored for the life sciences sector, including academia, pharmaceutical, and biotech industries. Their expertise lies in analyzing complex genomic data, particularly focusing on the "dark genome"—the 60% of the genome often overlooked—uncovering hidden biomarkers, novel mechanisms, and therapeutic targets. Key Features and Functionality: - TEnex Pipelines: Optimiz

Ligo Biosciences is pioneering the integration of deep-learning models to design novel enzymes, aiming to revolutionize chemical manufacturing by making it more efficient and environmentally sustainable. By training on billions of protein sequences and structures, their technology enables the creation of entirely new proteins engineered for functions that do not exist in nature. This approach accelerates enzyme design from years to days, offering scalable solutions for producing essential materi

Biotechnology platform creates a novel class of medicines that range in size between small molecules and antibodies, allowing doctors to treat patients effectively.

Business Analyzer works on Qlik Sense Desktop, the most modern and innovative BI tool, most recognized by the industry; with important advantages and novel features.

Oncimmune proprietary biomarker discovery engine, which is used to discover and validate novel biomarkers that can help stratify different cancer indications and autoimmune diseases.

Elements Contrast Clearance Analysis is a novel MRI-based methodology for the high resolution depiction of contrast clearance and accumulation, allowing for the differentiation of brain regions with high and low vascular activity.

Antibody therapeutics platform that focuses on the discovery and development of novel therapeutics for unmet medical needs in the field of antibody-drug conjugates therapy, enabling patients to recover from immune-mediated diseases

BenevolentAI is a pioneering AI-enabled drug discovery company that integrates advanced artificial intelligence with scientific expertise to accelerate the development of novel treatments for complex diseases. By leveraging its proprietary Benevolent Platform™, the company analyzes vast biomedical datasets to uncover new insights into disease biology, identify promising drug targets, and enhance the probability of clinical success. This approach streamlines the drug discovery process, reducing b

High-performing ads require captivating design, quality production, and data insights. SparkLabs’ creative experts utilize the latest AI advancements and deliver novel, top-quality ads to our customers at no additional charge.